Detalhe da pesquisa
1.
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Immunity
; 54(6): 1276-1289.e6, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836142
2.
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
J Virol
; 96(23): e0125022, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350154
3.
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
J Virol
; 95(9)2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563656
4.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
PLoS Pathog
; 16(9): e1008817, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970782
5.
HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells.
J Virol
; 94(7)2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941771
6.
HLA-C downregulation by HIV-1 adapts to host HLA genotype.
PLoS Pathog
; 14(9): e1007257, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180214
7.
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.
Analyst
; 145(16): 5638-5646, 2020 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32638712
8.
Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.
PLoS Pathog
; 11(8): e1005141, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317613
9.
Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.
PLoS Pathog
; 10(1): e1003895, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24465210
10.
Differential dysregulation of ß-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.
mBio
; 14(4): e0329322, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341489
11.
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.
Cell Rep
; 40(8): 111276, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981534
12.
Disrupted Peyer's Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus.
Front Immunol
; 13: 838328, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251032
13.
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.
Cell Rep
; 39(5): 110757, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477023
14.
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission.
Clin Microbiol Infect
; 28(1): 93-100, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400345
15.
More than the Eye Can See: Shedding New Light on SARS-CoV-2 Lateral Flow Device-Based Immunoassays.
ACS Appl Mater Interfaces
; 13(22): 25694-25700, 2021 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048220
16.
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
Lancet Microbe
; 2(9): e461-e471, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226893
17.
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.
PLoS One
; 16(4): e0249791, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826651
18.
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections.
medRxiv
; 2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34127977
19.
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.
Nat Microbiol
; 6(11): 1433-1442, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654917
20.
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike.
bioRxiv
; 2021 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564766